Injective is projected to decline to $4.48 by 2027, a -2% move from its current price of $4.70. INJ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell. Market sentiment sits at 29/100 (Fear) on the Fear & Greed Index.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via CoinGecko & CoinMarketCap · updated 7/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 29 | $4.45 | $4.70 | $4.96 | -0.07% |
| Jul 30 | $4.34 | $4.69 | $5.07 | -0.15% |
| Jul 31 | $4.26 | $4.69 | $5.16 | -0.22% |
| Aug 1 | $4.20 | $4.69 | $5.23 | -0.30% |
| Aug 2 | $4.14 | $4.68 | $5.30 | -0.37% |
| Aug 3 | $4.09 | $4.68 | $5.35 | -0.45% |
| Aug 4 | $4.04 | $4.68 | $5.41 | -0.52% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.04 | $4.68 | $5.41 | -0.52% |
| Week 2 | $3.79 | $4.65 | $5.71 | -1.04% |
| Week 3 | $3.60 | $4.63 | $5.95 | -1.56% |
| Week 4 | $3.44 | $4.60 | $6.16 | -2.08% |
| Week 5 | $3.31 | $4.58 | $6.34 | -2.59% |
| Week 6 | $3.19 | $4.55 | $6.51 | -3.10% |
| Week 7 | $3.08 | $4.53 | $6.66 | -3.61% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Injective is an interoperable Layer 1 blockchain designed for DeFi applications.
It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols.
Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.
Injective is currently trading at $4.70, with a market cap of $470.42M and a rank of 103. This position reflects a mid-cap, ecosystem-focused asset within the broader DeFi and Layer 1 space.
The year-by-year forecast paints a gradual to strong long-term upside. The 2026 average price is $4.59 and the 2027 average is $4.48, suggesting a muted near-term path before sharper upside emerges in the following years.
Longer term, the forecasts move higher, with 2030 average price seen at $14.39, rising to $100.34 by 2040 and $317.64 by 2050, accompanied by corresponding large ROI figures (213.6% in 2030, 2086.1% in 2040, and 6820.4% in 2050) and bullish sentiment. These numbers illustrate a strong bullish tilt for Injective over the coming years while acknowledging they are estimates.
A major floor 44.5% below — a decisive break under it would weaken the trend.
The nearest floor, 9.4% below — buyers have tended to step in here.
The nearest ceiling, 48.7% above — a clean break opens room to run.
A major ceiling 67.9% above — clearing it would confirm fresh momentum.
Key INJ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of INJ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.67 | Buy | $4.62 | Buy |
| MA 10 | $4.60 | Buy | $4.70 | Buy |
| MA 20 | $4.96 | Sell | $4.89 | Sell |
| MA 50 | $5.26 | Sell | $4.91 | Sell |
| MA 100 | $4.28 | Buy | $4.66 | Buy |
| MA 200 | $4.13 | Buy | $5.13 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.18 | Neutral |
| Stoch RSI (14) | 53.90 | Neutral |
| CCI (20) | -69.49 | Neutral |
| Williams %R (14) | -72.29 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -14.69 | Sell |
| Bollinger %B (20,2) | 0.27 | Neutral |
| Stochastic %K (14) | 27.71 | Neutral |
| TRIX (15) | -0.51 | Sell |
| Awesome (5,34) | -0.66 | Sell |
| Ultimate (7,14,28) | 43.30 | Neutral |
| Momentum (10) | -0.46 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 4.67 | Buy |
| ADX (14) | 15.60 | Neutral |
| ATR (14) | 0.21 | Info |
The 30-day technical picture remains constructive with a bullish tilt overall.
RSI14 sits at 40, suggesting room to move higher rather than being overbought. The short-term moving averages show SMA50 at $5.26 and SMA200 at $4.13, indicating a near-term price trend that leans toward the upside if near-term support holds.
Support is identified at $4.26 and resistance at $6.99, framing a trading range that sits above the current price and within a zone of potential upside. The 30-day range spans from $3.40 to $6.20, showing recent price volatility within a broad upward-bias context.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.74 | $4.59 | $5.06 | 0% | Neutral | |
| $3.25 | $4.48 | $6.70 | -2% | Neutral | |
| $8.57 | $12.58 | $20.02 | +174% | Bullish | |
| $12.33 | $19.07 | $31.86 | +316% | Bullish | |
| $8.88 | $14.39 | $25.03 | +214% | Bullish | |
| $8.60 | $14.58 | $26.25 | +218% | Bullish | |
| $18.07 | $31.95 | $59.29 | +596% | Bullish | |
| $24.09 | $44.36 | $84.61 | +866% | Bullish | |
| $26.29 | $50.38 | $98.52 | +998% | Bullish | |
| $22.82 | $45.45 | $90.96 | +890% | Bullish | |
| $45.15 | $100.34 | $220.67 | +20.9x | Bullish | |
| $142.94 | $317.64 | $730.58 | +68.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.74 | $4.59 | $6.53 | -2.34% |
| August 2026 | $4.33 | $5.27 | $6.71 | +14.90% |
| September 2026 | $3.56 | $4.39 | $5.69 | -16.77% |
| October 2026 | $3.31 | $4.14 | $5.46 | -5.72% |
| November 2026 | $3.47 | $4.38 | $5.85 | +5.83% |
| December 2026 | $2.93 | $3.74 | $5.06 | -14.68% |
Click any year to see its month-by-month INJ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Injective's 2026 outlook centres on $4.59, within a $2.74 to $5.06 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, INJ could reach as high as $6.70, with a base case around $4.48 and support toward $3.25 — roughly -2% from $4.70. A consolidation phase looks the most probable path here.
Expect INJ to range from $8.57 to $20.02 through 2028. The $12.58 average target implies a +174% move from current prices. That is up +180% on the projected 2027 average. Momentum favours further upside here.
The INJ price prediction for 2029 points to an average of $19.07 (low $12.33, high $31.86) — a potential gain of +316% on today's $4.70. Buyers look set to stay in control over this stretch.
In 2030, INJ is projected to trade between $8.88 and $25.03, averaging $14.39 — a potential gain of +214% from today's $4.70. That is -25% versus the projected 2029 average. Momentum favours further upside here.
Injective's 2031 outlook centres on $14.58, within a $8.60 to $26.25 range. That is up +1% on the projected 2030 average. That marks a +218% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, INJ could reach as high as $59.29, with a base case around $31.95 and support toward $18.07 — roughly +596% from $4.70. Momentum favours further upside here.
Expect INJ to range from $24.09 to $84.61 through 2033. The $44.36 average target implies a +866% move from current prices. That is up +39% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The INJ price prediction for 2034 points to an average of $50.38 (low $26.29, high $98.52) — a potential gain of +998% on today's $4.70. Momentum favours further upside here.
In 2035, INJ is projected to trade between $22.82 and $90.96, averaging $45.45 — a potential gain of +890% from today's $4.70. That is -10% versus the projected 2034 average. Buyers look set to stay in control over this stretch.
Injective's 2040 outlook centres on $100.34, within a $45.15 to $220.67 range. That is up +121% on the projected 2035 average. That marks a +20.9x change versus current levels. Momentum favours further upside here.
By 2050, INJ could reach as high as $730.58, with a base case around $317.64 and support toward $142.94 — roughly +68.2x from $4.70. Buyers look set to stay in control over this stretch.
Investing $1,000 in INJ today (≈ 212.765957 INJ) could be worth
$67,583.88
+$66,583.88 (+6658%) by 2050 · US Dollar
Based on the average projected INJ price of $317.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in INJwould be worth at today's price.
$1,000 invested in INJ on Jul 1, 2025 (≈ 92.89996 INJ) would be worth
$436.63
-$563.37 (-56.3%) today · 0.44× · US Dollar
Based on a INJ entry price of $10.76 vs. today's $4.7.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.54 | $1,035.49 | +3.5% |
| 1 month ago | $6.51 | $721.75 | -27.8% |
| 3 months ago | $2.87 | $1,637.41 | +63.7% |
| 6 months ago | $4.53 | $1,037.85 | +3.8% |
| 1 year ago | $10.76 | $436.63 | -56.3% |
| All time (1.1y) ago | $14.05 | $334.48 | -66.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our INJ forecast.
Our base-case forecast reaches $9.40 around 2028.
Implied market cap at $9.40: $940M
Across the multi-year forecast, Injective shows a clear bullish trajectory in later years. The 2026–2027 period carries neutral sentiment with 2026 avg $4.59 and 2027 avg $4.48 and ROI values around 0 to negative territory, indicating a cautious start before stronger upside.
From 2028 onward, the forecast turns bullish, with 2028 avg $12.58, 2029 avg $19.07, 2030 avg $14.39, and 2031 avg $14.58, all accompanied by positive sentiment. The momentum intensifies into 2032 ($31.95 avg) and 2033 ($44.36 avg), then accelerates further through 2034 ($50.38 avg) and 2040 ($100.34 avg) before reaching 2050 ($317.64 avg).
Notably, the long-term outlook features dramatic ROI expansion, with 2032 ROI 596, 2033 ROI 866.4, 2034 ROI 997.6, 2035 ROI 890.3, 2040 ROI 2086.1, and 2050 ROI 6820.4, all in bullish territory. These figures are estimates, not guarantees, and depend on market conditions, adoption, and broader crypto dynamics.
Tap a question to reveal the answer.
The 2030 average price is $14.39 with an ROI of 213.6% and sentiment BULLISH.
The forecast shows a bullish long-term trajectory, with average prices rising to $14.39 in 2030, $100.34 in 2040, and $317.64 in 2050, accompanied by substantial ROI (213.6% in 2030, 2086.1% in 2040, 6820.4% in 2050). These are estimates, not guarantees.
According to the forecast, the 2034 average price is $50.38 and the max is $98.52, with a bullish sentiment, suggesting a path where $50 could be reached around 2034.
The 2040 average price is $100.34 with an ROI of 2086.1% and sentiment BULLISH.
The current market cap is $470.42M.
Injective Community Discussion
0Share your Injective price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.